Nifty
:
23382.60
Sensex
:
74267.34
-165.15 (-0.70%)
-508.40 (-0.68%)
Nifty
Sensex
:
:
23382.60
74267.34
-165.15 (-0.70%)
-508.40 (-0.68%)

Sun Pharmaceutical Industries Ltd.

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 524715 | NSE: SUNPHARMA

NSE BSE
1799.20
29-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1844.3
  •  1852.8
  •  1785.3
  •  1844.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  10058572
  •  18147625466.7
  •  1916.6
  •  1548

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,32,096.23
  • 37.64
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,24,574.76
  • 0.89%
  • 5.17

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.48%
  • 2.02%
  • 5.31%
  • FII
  • DII
  • Others
  • 15.93%
  • 18.90%
  • 3.36%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.46
  • 9.44
  • 6.21

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.34
  • 12.24
  • 5.42

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.19
  • 30.28
  • 8.70

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.41
  • 38.26
  • 37.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.16
  • 4.97
  • 5.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.59
  • 21.77
  • 23.63

Earnings Forecasts:

(Updated: 30-05-2026)
Description
2024
2025
2026
2027
Adj EPS
50.54
55.19
65.04
76.19
P/E Ratio
35.60
32.60
27.66
23.61
Revenue
58240.5
65383.3
76765.2
84494.3
EBITDA
17081.4
18987.7
23526.5
27520.5
Net Income
12153.3
13271.8
15931.8
18782.1
ROA
12.64
12.5
12.9
12.78
P/B Ratio
5.38
4.69
4.15
3.64
ROE
15.67
14.97
16.04
16.41
FCFF
7302.74
11565
12239.7
22747.6
FCFF Yield
1.76
2.79
2.96
5.49
Net Debt
-29171.6
-35243.6
-38074.3
-27799.2
BVPS
334.55
383.64
433.72
494.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
14,611.79
12,958.84
12.76%
15,520.54
13,675.46
13.49%
14,478.31
13,291.39
8.93%
13,851.40
12,652.75
9.47%
Expenses
10,657.59
9,242.75
15.31%
10,725.97
9,666.44
10.96%
10,381.73
9,480.52
9.51%
9,778.78
9,045.13
8.11%
EBITDA
3,954.20
3,716.09
6.41%
4,794.57
4,009.02
19.59%
4,096.58
3,810.87
7.50%
4,072.62
3,607.62
12.89%
EBIDTM
27.06%
28.68%
30.89%
29.32%
28.29%
28.67%
29.40%
28.51%
Other Income
458.50
612.87
-25.19%
732.76
465.62
57.37%
900.39
482.09
86.77%
693.50
532.55
30.22%
Interest
85.89
49.14
74.79%
78.36
51.51
52.13%
99.86
69.17
44.37%
74.80
61.54
21.55%
Depreciation
775.47
663.79
16.82%
732.33
630.56
16.14%
729.50
625.91
16.55%
700.55
655.13
6.93%
PBT
3,551.34
3,254.35
9.13%
4,227.16
3,476.40
21.60%
4,167.61
3,597.88
15.84%
3,172.77
3,423.50
-7.32%
Tax
827.62
1,093.71
-24.33%
826.07
558.86
47.81%
1,030.52
567.21
81.68%
870.15
552.25
57.56%
PAT
2,723.72
2,160.64
26.06%
3,401.09
2,917.54
16.57%
3,137.09
3,030.67
3.51%
2,302.62
2,871.25
-19.80%
PATM
18.64%
16.67%
21.91%
21.33%
21.67%
22.80%
16.62%
22.69%
EPS
11.31
8.96
26.23%
14.04
12.10
16.03%
13.00
12.67
2.60%
9.50
11.82
-19.63%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
58,462.04
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
29,065.91
26,415.54
31,308.14
28,108.61
Net Sales Growth
11.19%
8.42%
10.51%
13.53%
15.39%
2.01%
12.98%
10.03%
-15.63%
11.38%
 
Cost Of Goods Sold
11,543.68
10,747.36
10,662.61
10,662.16
10,351.54
8,690.08
9,230.45
7,868.97
7,351.71
8,164.20
6,170.19
Gross Profit
46,918.36
41,831.08
37,834.24
33,223.52
28,302.95
24,808.06
23,607.05
21,196.94
19,063.83
23,143.94
21,938.42
GP Margin
80.25%
79.56%
78.01%
75.70%
73.22%
74.06%
71.89%
72.93%
72.17%
73.92%
78.05%
Total Expenditure
41,544.07
37,492.28
35,747.77
32,298.12
28,772.68
25,030.42
25,863.35
22,792.27
20,880.73
21,625.92
19,950.29
Power & Fuel Cost
-
750.40
760.78
830.05
702.78
595.58
586.18
580.15
527.76
488.46
510.66
% Of Sales
-
1.43%
1.57%
1.89%
1.82%
1.78%
1.79%
2.00%
2.00%
1.56%
1.82%
Employee Cost
-
9,973.12
9,429.06
8,296.03
7,300.83
6,126.18
5,703.57
5,297.62
4,707.99
4,311.85
4,204.06
% Of Sales
-
18.97%
19.44%
18.90%
18.89%
18.29%
17.37%
18.23%
17.82%
13.77%
14.96%
Manufacturing Exp.
-
2,261.24
2,186.62
1,936.77
1,880.71
3,486.62
3,341.64
3,399.20
3,490.23
3,393.59
3,243.54
% Of Sales
-
4.30%
4.51%
4.41%
4.87%
10.41%
10.18%
11.69%
13.21%
10.84%
11.54%
General & Admin Exp.
-
5,646.06
5,252.93
4,256.12
3,270.55
2,224.76
2,431.10
2,033.01
2,112.01
1,834.14
1,891.68
% Of Sales
-
10.74%
10.83%
9.70%
8.46%
6.64%
7.40%
6.99%
8.00%
5.86%
6.73%
Selling & Distn. Exp.
-
6,576.86
5,780.26
5,226.24
4,096.33
3,103.96
3,654.48
2,621.13
1,864.55
2,520.64
2,262.35
% Of Sales
-
12.51%
11.92%
11.91%
10.60%
9.27%
11.13%
9.02%
7.06%
8.05%
8.05%
Miscellaneous Exp.
-
1,537.24
1,675.51
1,090.75
1,169.94
803.24
915.93
992.19
826.48
913.04
2,262.35
% Of Sales
-
2.92%
3.45%
2.49%
3.03%
2.40%
2.79%
3.41%
3.13%
2.92%
5.93%
EBITDA
16,917.97
15,086.16
12,749.08
11,587.56
9,881.81
8,467.72
6,974.15
6,273.64
5,534.81
9,682.22
8,158.32
EBITDA Margin
28.94%
28.69%
26.29%
26.40%
25.56%
25.28%
21.24%
21.58%
20.95%
30.93%
29.02%
Other Income
2,785.15
2,150.57
1,628.24
693.75
1,437.42
859.17
651.59
1,059.44
912.08
1,030.20
658.25
Interest
338.91
231.36
238.47
172.00
127.35
141.43
302.73
555.25
517.57
399.80
523.24
Depreciation
2,937.85
2,575.39
2,556.64
2,529.43
2,143.74
2,079.95
2,052.78
1,753.25
1,499.84
1,264.75
1,037.53
PBT
15,118.88
14,429.98
11,582.21
9,579.88
9,048.14
7,105.51
5,270.23
5,024.58
4,429.48
9,047.87
7,255.80
Tax
3,554.36
2,772.03
1,439.45
847.59
1,075.50
514.69
822.80
600.88
911.04
1,211.57
913.77
Tax Rate
23.51%
20.16%
12.98%
9.01%
24.00%
18.39%
16.42%
15.77%
26.19%
13.39%
13.91%
PAT
11,564.52
10,944.39
9,614.79
8,521.48
3,289.27
2,916.15
3,779.76
2,666.88
2,121.14
6,954.44
4,544.26
PAT before Minority Interest
11,535.29
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
3,209.32
2,567.94
7,836.30
5,656.86
Minority Interest
-29.23
-35.71
-33.65
-39.36
-116.55
631.47
-407.03
-542.44
-446.80
-881.86
-1,112.60
PAT Margin
19.78%
20.82%
19.83%
19.42%
8.51%
8.71%
11.51%
9.18%
8.03%
22.21%
16.17%
PAT Growth
5.32%
13.83%
12.83%
159.07%
12.79%
-22.85%
41.73%
25.73%
-69.50%
53.04%
 
EPS
48.20
45.61
40.07
35.52
13.71
12.15
15.75
11.12
8.84
28.99
18.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
72,218.02
63,666.75
55,995.38
48,011.22
46,462.78
45,264.45
41,409.06
38,314.11
36,639.67
32,982.48
Share Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
240.66
Total Reserves
71,978.09
63,426.82
55,755.45
47,771.29
46,222.85
45,024.52
41,169.13
38,074.18
36,397.10
32,736.26
Non-Current Liabilities
-2,987.13
-2,714.34
-1,997.80
-1,316.37
-1,515.17
246.05
76.72
46.43
599.87
2,169.59
Secured Loans
0.00
0.00
0.00
0.00
251.25
257.49
109.47
217.69
185.59
79.31
Unsecured Loans
2.52
1.33
0.00
229.92
646.88
1,771.43
1,413.14
1,554.40
1,250.49
3,030.99
Long Term Provisions
473.80
413.89
342.91
369.07
327.12
511.00
430.39
404.46
1,211.11
1,895.86
Current Liabilities
18,194.21
16,983.77
19,906.38
17,208.45
16,145.63
15,706.43
17,339.62
19,864.32
17,887.02
13,143.96
Trade Payables
6,184.34
5,653.30
5,681.52
4,489.76
3,973.66
3,583.64
4,147.87
4,766.20
4,395.39
3,582.92
Other Current Liabilities
3,254.45
2,716.85
2,603.51
2,926.73
4,965.34
2,535.02
1,761.72
1,875.93
2,673.68
1,134.27
Short Term Borrowings
1,867.11
2,844.36
5,958.26
468.52
2,444.90
5,549.38
8,370.76
7,979.70
6,654.92
5,206.12
Short Term Provisions
6,888.31
5,769.26
5,663.09
9,323.44
4,761.73
4,038.39
3,059.27
5,242.49
4,163.03
3,220.65
Total Liabilities
87,693.03
81,395.37
77,224.05
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,917.42
52,381.28
Net Block
22,586.28
23,248.15
24,065.44
22,665.16
21,552.98
22,846.91
21,836.54
18,852.65
17,675.17
15,872.25
Gross Block
45,949.61
44,320.48
43,099.95
38,707.36
35,578.99
35,115.97
31,687.04
26,948.80
24,466.42
22,180.41
Accumulated Depreciation
23,363.33
21,072.33
19,034.51
16,042.20
14,026.01
12,269.06
9,850.50
8,096.15
6,791.25
6,308.16
Non Current Assets
35,068.56
37,921.02
37,341.33
32,093.59
33,668.21
33,423.01
31,069.75
30,473.12
25,963.77
22,439.98
Capital Work in Progress
6,643.96
5,353.88
4,973.16
1,286.80
1,566.83
1,220.34
1,411.15
2,465.16
2,801.38
2,175.45
Non Current Investment
4,697.70
6,441.23
5,451.73
5,214.65
6,482.39
5,245.75
3,951.81
3,052.25
961.00
1,116.07
Long Term Loans & Adv.
1,016.49
2,784.59
2,757.87
2,880.86
4,061.34
4,104.39
3,848.41
6,052.97
3,844.04
2,322.87
Other Non Current Assets
124.13
93.17
93.13
46.12
4.67
5.62
21.84
50.09
682.18
953.34
Current Assets
52,594.06
43,433.11
39,861.94
34,864.60
30,442.08
31,654.16
31,069.19
31,635.90
32,947.06
29,934.11
Current Investments
13,656.10
8,584.54
9,372.61
7,633.94
3,130.06
4,897.36
3,950.72
4,090.62
230.88
713.81
Inventories
10,243.33
9,868.29
10,513.05
8,925.13
8,997.02
7,874.99
7,885.98
6,880.69
6,832.81
6,422.54
Sundry Debtors
13,046.11
11,249.37
11,438.51
10,484.59
9,061.40
9,421.24
8,884.20
7,815.28
7,202.61
6,775.66
Cash & Bank
11,331.62
10,520.68
5,770.29
5,033.35
6,445.51
6,487.55
7,275.60
9,929.38
15,140.84
13,181.65
Other Current Assets
4,316.90
755.99
745.91
775.01
2,808.09
2,973.02
3,072.69
2,919.93
3,539.92
2,840.45
Short Term Loans & Adv.
3,692.36
2,454.24
2,021.57
2,012.58
1,488.98
1,431.54
1,806.39
2,028.62
2,828.26
2,317.13
Net Current Assets
34,399.85
26,449.34
19,955.56
17,656.15
14,296.45
15,947.73
13,729.57
11,771.58
15,060.04
16,790.15
Total Assets
87,662.62
81,354.13
77,203.27
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,910.83
52,374.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
14,072.09
12,134.98
4,959.33
8,984.54
6,170.37
6,554.77
2,196.45
3,907.15
7,082.21
6,685.86
PBT
13,752.13
11,087.89
9,408.43
4,481.32
2,799.37
5,009.59
3,810.20
3,478.98
9,047.87
6,570.63
Adjustment
1,120.36
1,554.40
2,722.56
1,974.95
1,809.85
1,992.54
1,968.66
1,382.22
500.67
1,856.92
Changes in Working Capital
-323.56
1,062.13
-5,661.82
1,559.05
2,564.09
898.55
-2,696.00
-212.31
-409.21
246.77
Cash after chg. in Working capital
14,548.93
13,704.42
6,469.17
8,015.32
7,173.31
7,900.68
3,082.86
4,648.89
9,139.33
8,674.32
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-476.84
-1,569.44
-1,509.84
969.22
-1,002.94
-1,345.91
-886.41
-741.74
-2,057.12
-1,988.46
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5,306.16
-690.20
-7,943.68
-5,724.74
536.22
-2,588.84
-681.25
-3,370.81
-4,221.60
-4,371.59
Net Fixed Assets
-548.72
-420.26
-573.97
-1,120.95
-8,061.35
-737.44
-543.38
-1,471.92
-1,217.15
2,214.23
Net Investments
19.86
183.27
2,935.63
-11.67
1,824.52
542.39
451.15
978.04
3,038.39
3,504.47
Others
-4,777.30
-453.21
-10,305.34
-4,592.12
6,773.05
-2,393.79
-589.02
-2,876.93
-6,042.84
-10,090.29
Cash from Financing Activity
-7,905.82
-6,710.16
2,376.07
-5,193.46
-5,980.48
-5,715.14
-2,730.52
-1,539.26
-2,285.39
-1,888.53
Net Cash Inflow / Outflow
860.11
4,734.62
-608.28
-1,933.66
726.11
-1,749.21
-1,215.32
-1,002.92
575.22
425.74
Opening Cash & Equivalents
9,285.65
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36
8,031.69
7,183.49
Closing Cash & Equivalent
10,268.77
9,285.65
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36
8,031.69

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
301.00
265.36
233.38
200.11
193.65
188.66
172.59
159.69
152.70
137.03
ROA
12.99%
12.17%
11.88%
5.20%
3.54%
6.58%
5.17%
4.24%
0.00%
11.39%
ROE
16.16%
16.13%
16.46%
7.21%
4.98%
9.66%
8.05%
6.85%
0.00%
19.32%
ROCE
19.89%
17.60%
17.24%
9.28%
5.68%
10.07%
8.68%
8.40%
0.00%
18.64%
Fixed Asset Turnover
1.16
1.11
1.07
1.81
1.74
1.78
1.92
1.99
1.29
1.34
Receivable days
84.33
85.38
91.17
53.09
54.88
56.22
54.10
53.53
83.25
76.12
Inventory Days
69.81
76.70
80.83
48.68
50.10
48.40
47.84
48.88
78.98
77.46
Payable days
201.01
194.01
174.10
149.21
158.71
152.86
77.81
90.19
85.47
75.24
Cash Conversion Cycle
-46.88
-31.93
-2.10
-47.44
-53.73
-48.24
24.13
12.23
76.75
78.34
Total Debt/Equity
0.03
0.04
0.11
0.02
0.08
0.18
0.25
0.27
0.27
0.26
Interest Cover
60.44
47.50
55.70
36.19
20.79
17.55
7.86
7.72
23.63
13.56

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Sun Pharma Inds. - Quarterly Results
    23rd May 2026, 00:00 AM

    Read More
  • Sun Pharma reports 26% rise in Q4 consolidated net profit
    22nd May 2026, 16:22 PM

    The total consolidated income of the company has increased by 11.04% at Rs 15,070.29 crore for Q4FY26

    Read More
  • Sun Pharmaceutical to acquire all outstanding shares of Organon
    27th Apr 2026, 10:10 AM

    The proposed acquisition of Organon is aligned with Sun Pharma’s strategy of growing its Innovative Medicines business

    Read More
  • Sun Pharmaceutical launches semaglutide injections in India
    21st Mar 2026, 14:55 PM

    Noveltreat is indicated for chronic weight management in adults as an adjunct to a reduced calorie diet & increased physical activity

    Read More
  • Sun Pharmaceutical secures USFDA’s nod for review of ILUMYA
    17th Mar 2026, 09:50 AM

    The FDA regulatory action date for this sBLA is expected by October 29, 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.